Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

C Andersson; L van Gaal; I D Caterson; P Weeke; W P T James; W Couthino; Nicholas Finer; A M Sharma; A P Maggioni; C Torp-Pedersen

doi:10.1007/s00125-012-2584-3

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

C Andersson, L van Gaal, I D Caterson, P Weeke, W P T James, W Couthino, Nicholas Finer, A M Sharma, A P Maggioni, C Torp-Pedersen

58 Citationer (Scopus)

Abstract

The optimal HbA(1c) concentration for prevention of macrovascular complications and deaths in obese cardiovascular high-risk patients with type 2 diabetes remains to be established and was therefore studied in this post hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial, which enrolled overweight and obese patients with type 2 diabetes and/or cardiovascular disease.

Originalsprog	Engelsk
Tidsskrift	Diabetologia
Vol/bind	55
Udgave nummer	9
Sider (fra-til)	2348-55
Antal sider	8
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-012-2584-3
Status	Udgivet - 2012

Adgang til dokumentet

10.1007/s00125-012-2584-3

Citationsformater

Andersson, C., van Gaal, L., Caterson, I. D., Weeke, P., James, W. P. T., Couthino, W., Finer, N., Sharma, A. M., Maggioni, A. P., & Torp-Pedersen, C. (2012). Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia, 55(9), 2348-55. https://doi.org/10.1007/s00125-012-2584-3

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. / Andersson, C; van Gaal, L; Caterson, I D et al.
I: Diabetologia, Bind 55, Nr. 9, 2012, s. 2348-55.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Andersson, C, van Gaal, L, Caterson, ID, Weeke, P, James, WPT, Couthino, W, Finer, N, Sharma, AM, Maggioni, AP & Torp-Pedersen, C 2012, 'Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes', Diabetologia, bind 55, nr. 9, s. 2348-55. https://doi.org/10.1007/s00125-012-2584-3

@article{e9eb5730eea7458aadf8c86fcca9b63e,

title = "Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes",

abstract = "The optimal HbA(1c) concentration for prevention of macrovascular complications and deaths in obese cardiovascular high-risk patients with type 2 diabetes remains to be established and was therefore studied in this post hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial, which enrolled overweight and obese patients with type 2 diabetes and/or cardiovascular disease.",

author = "C Andersson and {van Gaal}, L and Caterson, {I D} and P Weeke and James, {W P T} and W Couthino and Nicholas Finer and Sharma, {A M} and Maggioni, {A P} and C Torp-Pedersen",

year = "2012",

doi = "10.1007/s00125-012-2584-3",

language = "English",

volume = "55",

pages = "2348--55",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "9",

}

TY - JOUR

T1 - Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

AU - Andersson, C

AU - van Gaal, L

AU - Caterson, I D

AU - Weeke, P

AU - James, W P T

AU - Couthino, W

AU - Finer, Nicholas

AU - Sharma, A M

AU - Maggioni, A P

AU - Torp-Pedersen, C

PY - 2012

Y1 - 2012

N2 - The optimal HbA(1c) concentration for prevention of macrovascular complications and deaths in obese cardiovascular high-risk patients with type 2 diabetes remains to be established and was therefore studied in this post hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial, which enrolled overweight and obese patients with type 2 diabetes and/or cardiovascular disease.

AB - The optimal HbA(1c) concentration for prevention of macrovascular complications and deaths in obese cardiovascular high-risk patients with type 2 diabetes remains to be established and was therefore studied in this post hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial, which enrolled overweight and obese patients with type 2 diabetes and/or cardiovascular disease.

U2 - 10.1007/s00125-012-2584-3

DO - 10.1007/s00125-012-2584-3

M3 - Journal article

C2 - 22638548

SN - 0012-186X

VL - 55

SP - 2348

EP - 2355

JO - Diabetologia

JF - Diabetologia

IS - 9

ER -

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater